SUB-TENON'S ANECORTAVE ACETATE EFFECTIVE FOR INTRAOCULAR PRESSURE REDUCTION

Studies are underway to test the efficacy of sub-tenon's injection of anecortave acetate for the reduction of intraocular pressure in glaucoma patients.

In a study in the American Journal of Ophthalmology 2009;147:45-50, eyes with ta mean pretreatment IOP of 31.3 had a rapid and significant decrease of IOP by 9.5mmHg wihtin 1 week. by 4 weeks th emean IOP decreased by 12.7mmHg. These reductions were maintained at 6 months and 12 months. No adverse side effects were noted.

This was a small pilot study that lacked control data, howerver anecortave acetate may be a promising contender for IOP reduction in eyes with glaucoma.

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH